Adaptin Bio (APTN) Research & Development (2024 - 2026)

Adaptin Bio has disclosed Research & Development across 3 years of filings, most recently posting $138167.0 for Q2 2026.

• In Q2 2026, Research & Development fell 59.4% year-over-year to $138167.0; the TTM figure through Jun 2026 stood at $1.7 million (up 24.75% YoY), while the FY2025 annual figure was $1.8 million, down 2.76% from the prior year.
• Research & Development came in at $138167.0 for Q2 2026 at Adaptin Bio, down from $165577.0 in the prior quarter.
• In the past five years, Research & Development ranged from a high of $778664.0 in Q3 2025 to a low of $62133.0 in Q1 2025.
• Average Research & Development over 3 years is $390250.1, with a median of $299196.0 recorded in 2024.
• Year-over-year, Research & Development sank 68.77% in 2025 and surged 166.49% in 2026.
• Over 3 years, Research & Development stood at $258058.0 in 2024, then jumped by 129.81% to $593035.0 in 2025, then plunged by 76.7% to $138167.0 in 2026.
• Per Business Quant data, the three most recent Research & Development figures were $138167.0 in Q2 2026, $165577.0 in Q1 2026, and $593035.0 in Q4 2025.